Factory 99% Rivastigmine Tartrate CAS 129101-54-8 Chemical Intermediate Rivastigmine Tartrate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A428
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Rivastigmine Tartrate
• CAS: 129101-54-8
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Anti-Inflammatory
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Rivastigmine Tartrate
Appearance	White Powder
CAS NO.	129101-54-8
Molecular Formula	C18H28N2O8
Storage	Keep in a cool, dry, dark location

 

Rivastigmine Tartrate, also known as ENA 713 or SDZ-ENA 713, is a pharmaceutical agent primarily used in medical research and treatment.

 

 

1. Pharmaceutical Research: It is employed in scientific studies as a cholinesterase (ChE) inhibitor, specifically targeting butyrylcholinesterase (BChE) and acetylcholinesterase (AChE).
2. Drug Development: Used in the development of medications for neurological disorders due to its ability to cross the blood-brain barrier (BBB).
3. Therapeutic Agent: Under investigation for its potential in treating dementia associated with mild to moderate Alzheimer's disease and Parkinson's disease.

1. Cholinesterase Inhibition: By inhibiting BChE and AChE, Rivastigmine Tartrate enhances cholinergic neurotransmission, which is crucial for cognitive function.
2. Neuroprotective Effects: Demonstrated to improve behavioral impairments in animal models, possibly through its neuroprotective mechanisms.
3. Anti-inflammatory Actions: In vitro studies suggest it may reduce the production of certain inflammatory cytokines, indicating potential anti-inflammatory properties.